Introduction {#s1}
============

Recent publications have demonstrated reductions in snoring with several minimally invasive surgery (MIS) methods of the soft palate including radiofrequency (RF) surgery and palatal implant (PI) [@pone.0097186-Bck1], [@pone.0097186-Choi1]. Despite modest effects in the treatment of obstructive sleep apnea [@pone.0097186-Bck1]--[@pone.0097186-Franklin1], patients often wish to receive MIS for habitual snoring. However, the efficacy in reducing snoring has mainly been determined by self-reported questionnaires in the past. Further, the definition of surgical success in snoring treatment has not been universally defined. To date, changes in snoring sound characteristics following MIS have not been demonstrated.

Many cohort studies and a few randomized controlled trials or clinical controlled trials have compared MIS with a placebo [@pone.0097186-Stuck2]--[@pone.0097186-Maurer1], different energy generators [@pone.0097186-Blumen1], different material rigidity [@pone.0097186-Skjstad1], or different operative techniques [@pone.0097186-Bassiouny1], [@pone.0097186-Balseviius1]. RF of the soft palate produces volumetric tissue reduction [@pone.0097186-Fang1] and selective scar tissue [@pone.0097186-Stuck2] to reduce obstruction and induce stiffness. However, the RF energy delivered to the soft palate can be inadequate and may result in residual or recurrent snoring [@pone.0097186-Bck2], [@pone.0097186-Blumen2]. PI can decrease palatal flutter by increasing the rigidity of the soft palate through implant identity and tissue fibrosis [@pone.0097186-Ho1], [@pone.0097186-Caples1]. In addition, PI can be chronically retained in the muscle layer of the soft palate thereby producing a long-term anti-snoring effect [@pone.0097186-Neruntarat1], [@pone.0097186-Rotenberg1]. Nevertheless, whether PI provides a better efficacy in the treatment of snoring than RF surgery is still unknown.

The primary aim of the current study was to compare the anti-snoring effect between PI and RF by subjective assessments in a randomized controlled parallel trial. The secondary aim was to explore and compare the acoustic changes in snoring sounds after PI and RF.

Materials and Methods {#s2}
=====================

The protocol for this trial and supporting CONSORT checklist are available as supporting information; see [Protocol S1](#pone.0097186.s001){ref-type="supplementary-material"} and [Checklist S1](#pone.0097186.s002){ref-type="supplementary-material"}.

Ethics Statement {#s2a}
----------------

This study was approved by the Institutional Review Board of Chang Gung Memorial Hospital and conducted according to the principles expressed in the Declaration of Helsinki. Signed informed consent was obtained from all patients. Full details of the trial protocol can be found in the Supplementary Appendix, available with the full text of this article at [www.plosone.org](http://www.plosone.org).

Participants and Setting {#s2b}
------------------------

This study was a prospective, randomized, parallel-controlled, open labeled trial that was conducted from August 1, 2010 to July 30, 2012 in a tertiary medical center (Department of Otorhinolaryngology, Head and Neck Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan). The flowchart diagram following the CONSORT 2010 guideline demonstrated our study design ([Figure 1](#pone-0097186-g001){ref-type="fig"}). No important changes to methods (such as eligibility criteria) have been made after trial commencement. Thirty-four patients with habitual snoring and apnea-hypopnea index (AHI) ≤15 events/h confirmed by standard full-night polysomnography were prospectively recruited from October 1, 2010 to March 30, 2012 for the treatment of snoring by the two MIS methods. Standard level I polysomnography (Nicolet UltraSom System, Madison, WI, USA) was performed in the sleep laboratory to document sleep parameters in each patient. All respiratory events were scored as per standard criteria [@pone.0097186-Iber1].

![Schematic diagram (CONSORT 2010 flowchart diagram) summarizing the study design.\
AHI: apnea-hypopnea index. PI: palatal implant; RF, radiofrequency. SOS: snoring outcomes survey. VAS: visual analogue scale.](pone.0097186.g001){#pone-0097186-g001}

The inclusion criteria were: a) age, 18--60 years; b) body mass index, ≤30 kg/m^2^; c) length of the soft palate (from the uvula base to the hard palate-soft palate junction) ≥2.5 cm and the width of the base of the uvular ≥1.0 cm ([Figure 2](#pone-0097186-g002){ref-type="fig"}). These criteria were basically in accordance with the criteria for a PI procedure as described in the literature [@pone.0097186-Friedman1], [@pone.0097186-Maurer1], [@pone.0097186-Skjstad1], [@pone.0097186-Ho1]. Patients were excluded if they had tonsillar hypertrophy (tonsil size ≥3), high tongue position (Friedman tongue position ≥4), retrognathia, craniofacial abnormalities, trismus, allergy to anesthetic or poorly controlled medical disorders such as hypertension, bleeding tendency, cardiovascular disorder, and stroke. Four patients were excluded due to 'Not meeting inclusion criteria (*n* = 3)' and 'Declined to participate (*n* = 1)'.

![Favorable anatomy for the MIS of the soft palate in anti-snoring treatment.\
(A) Frontal view showing the longitudinal length from the uvular base to the hard palate-soft palate junction ≥ 2.5 cm and the lateral width of the uvular base ≥ 1.0 cm. (B) Lateral view illustrating the anterior-posterior width of the uvular base ≥ 1.0 cm.](pone.0097186.g002){#pone-0097186-g002}

Therefore, 30 participants were therefore enrolled in the present study. Subjective assessments of snoring and snoring sound recording were conducted after enrollment. The randomization procedure assured balanced design in subjective snoring severity and we stratified our subjects into two subgroups: 'VAS \>7' (*n* = 12) and 'VAS ≤7' subgroups (*n* = 18). Computer-generated lists of random numbers were created using Random Number Generators of SPSS software for allocation of the participants and were stratified by center with a 1:1 allocation using a fixed block size of 6 (Rv. Uniform \[0, 1\]) in both subgroups. Participants were enrolled by four authors (LAL, YLL, NHC, and HYL). The allocation sequence was concealed from the researcher (CGH) before operation and the MIS procedure was performed by a single surgeon (HYL) who adhered to our computer-generated randomization protocol. Participants were randomly allocated to either PI or RF group ([Figure 1](#pone-0097186-g001){ref-type="fig"}). Half of the patients were randomized to the PI group and the remaining patients were randomized to the RF group. Subjective and objective assessments were re-measured 3 months following the MIS.

Snoring Sound Assessment {#s2c}
------------------------

### Subjective snoring questionnaires {#s2c1}

The snoring of all subjects was assessed by two subjective surveys: visual analogue scale (VAS) and snore outcomes survey (SOS) questionnaires. The participants, based on descriptions from their spouse or bed partner, were asked to estimate the severity of their snoring using a 10 cm VAS from 0 (no snoring) to 10 (very severe snoring, bed partner leaves the room). The SOS questionnaire was comprised of eight Likert-type items to comprehensively evaluate the duration, loudness, and frequency of snoring. The scale of the SOS was normalized from 0 (worst) to 100 (best) [@pone.0097186-Gliklich1]. The Mandarin Chinese version of the SOS has been validated and repeatedly used as an outcome measure in obstructive sleep apnea patients [@pone.0097186-Chen1].

### Objective snoring sound analysis {#s2c2}

We collected full-night snoring sounds of each subject in a standard sleep laboratory using a snore detection system as described previously [@pone.0097186-Lee1]. An external measurement microphone (TEDS type 46AE, G.R.A.S. Corp., Holte, Denmark) was positioned 100 cm above the patient\'s head to record the snoring sounds in the sleep laboratory [@pone.0097186-Lee1], [@pone.0097186-BenIsrael1]. Calibration of sound pressure level was performed before each test. The environmental sounds of the study room were recorded for 10 minutes as the background signal and analyzed. The recorded snoring sounds were detected by portable data cards (PXI 4462, National Instruments Corp., Austin, TX, USA) and processed by digital recording software (Sound & Vibration Toolkit for Labview, National Instruments Corp., Austin, TX, USA) at a sample rate of 44,100 Hz. The frequency power spectrum was created by fast Fourier transformation (range, 3.15 Hz--2,000 Hz).

After the patients had fallen asleep naturally and started to snore, we continually recorded the snoring sounds for 6 hours. Snoring sound signals were analyzed by the specially designed computer program Snore Map (Chang Gung Memorial Hospital, Taoyuan, Taiwan, R.O.C.). In accordance with an observer-blind study, the snoring sound recorder and the analyzer (JFY) were blind to the results of the randomization. The details of our snoring sound detection algorithm have been described elsewhere [@pone.0097186-Lee1]. Using this method, we calculated the snoring index (SI \[event/hour\]), maximal sound intensity (Imax \[dB\]), mean sound intensity (Imean \[dB\]), peak sound frequency (Fpeak \[Hz\]), and mean sound frequency (Fmean \[Hz\]) in 4 different frequency domains (40 Hz--2,000 Hz \[total-frequency, Total\], 40 Hz--300 Hz \[low-frequency, B1\], 301 Hz--850 Hz \[mid-frequency, B2\], and 851 Hz--2,000 Hz \[high-frequency, B3\]).

In this study, we focused on the acoustic changes of Total- and B1-frequency domains due to the soft palate producing low frequency snores (\<300 Hz) [@pone.0097186-Herzog1] and being operated on by the two different MIS.

MIS {#s2d}
---

The patients underwent a session of either PI surgery or temperature-controlled RF surgery under local anesthesia on an outpatient basis. Before the MIS procedure, the palate was anesthetized by applying a topical 10% xylocaine spray followed by injection of a local anesthetic mixture of 2% lidocaine with diluted adrenaline (1:100,000). All of the study subjects were given antibiotics (ampicillin 500 mg q6h for 5 days) and analgesics (acetaminophen 500 mg q6h when required).

### PI surgery {#s2d1}

Using the delivery tool of the PI system (Pillar, Medtronic Inc., Jacksonville, FL, USA), the mucosa of the soft palate close to the hard palate-soft palate junction (approximate 0.5 cm) was punctured in the midline [@pone.0097186-Goessler1]. The needle was inserted to the uvular muscle and moved parallel to the curve of the soft palate towards the tip of the uvula. After reaching the insertion point, the implant was delivered steadily after which the needle was withdrawn. This process was repeated for the second and third implants in the bilateral para-midline with a 0.2 cm horizontal distance from the first implant ([Figure 3](#pone-0097186-g003){ref-type="fig"}).

![Palatal implant surgery.\
(A) Preoperative frontal view demonstrating the 3 operative sites of the soft palate (0.5 cm below the hard palate-soft palate junction; 0.2 cm between the midline and para-midline sites). (B) Postoperative frontal view showing the stiffened zone (grey zone) by the implant (1.8 cm×0.94 cm).](pone.0097186.g003){#pone-0097186-g003}

### RF surgery {#s2d2}

RF energy was delivered via a generator (Somnus Model S2, Gyrus-ACMI Corporation, Maple Grove, MN, USA) with the power set to 10 watts and the maximal target temperature to 85°C. The needle electrode was inserted through the mucosa into the muscle layer at the entry points (approximately 1 cm below the hard palate-soft palate junction). The electrode was kept in place until 600 J had been delivered at the midline and 300 J at both para-midline sites (approximately 1 cm horizontal distance; [Figure 4](#pone-0097186-g004){ref-type="fig"}) [@pone.0097186-Balseviius1], [@pone.0097186-Back1].

![Radiofrequency surgery.\
(A) Preoperative frontal view illustrating the 3 operative sites of the soft palate (1.0 cm below the hard palate-soft palate junction; 1.0 cm between the midline and para-midline sites). (B) Postoperative frontal view demonstrating the stiffened zone (grey zone) by the RF energy (1.0 cm×2.6 cm).](pone.0097186.g004){#pone-0097186-g004}

Outcomes {#s2e}
--------

The mean change in VAS before and after MIS was the primary outcome measurement. The mean changes in SOS and acoustic characteristics of snoring sound were the secondary outcome measurements. Postoperative 'VAS ≤3' was traditionally defined as 'major response' [@pone.0097186-Powell1]. For a comprehensive profile of the outcomes, we further created another definition of 'fine response': 'postoperative VAS ≤5 plus SOS ≥60' post hoc in the present study. Accordingly, we compare a 'good response' rate, defined herein by a postoperative VAS ≤3 or postoperative VAS ≤5 plus SOS ≥60, between the PI and RF groups.

Statistical Analysis {#s2f}
--------------------

Statistical analyses were performed using SPSS software (version 17.0; SPSS, Inc., Chicago, IL, USA) and G\*Power (version 3.1.5; University Kiel, Germany). For the relative small sample size of the present study, we analyzed all variables using non-parametric approaches. The sample size for this study was estimated using the primary outcome effects (VAS) in two previously published studies [@pone.0097186-Friedman1], [@pone.0097186-Fang1]. Using a two-tailed Wilcoxon signed-rank test for calculating the sample size (normal parent distribution; effect size, 1.0; type I error, 0.05; power, 80%), we got a sample size of 11. For considering a 20% drop-out rate to fulfill the criteria of intention-to-treat analysis, we needed at least 14 participants to attend this study. Accordingly, we decided to enroll 30 patients with 15 in each group for showing the difference in mean before and after VAS scores. Two interim analyses were performed at the end of the first year during the trial: 1) the levels of significance maintained an overall *P* value of 0.05 and were calculated according to the O\'Brien-Fleming stopping boundaries, and 2) this final analysis used a *Z* score of 1.985 with an associated *P* value of 0.0471 [@pone.0097186-Galgiani1]. We planned to stop early if exceptional benefit or harm had been shown.

Further implementing the Kolmogorov-Smirnov test, distributions of patient clinical characteristics, subjective and objective snoring parameters were non-Gaussian and the descriptive statistics of these variables were presented as means (standard errors). Percentage (%) of change (\[after value-before value\]/\[before value\] × 100) in subjective snoring as well as in objective acoustic factors and differences between groups were analyzed with the Wilcoxon signed ranks test or the Mann-Whitney *U* test, as appropriate. Categorical variables were analyzed with the Fisher\'s exact test or the chi-square test. A *P* value of less than 0.05 was considered to be statistically significant.

Results {#s3}
=======

Subjects {#s3a}
--------

[Table 1](#pone-0097186-t001){ref-type="table"} summarizes baseline anthropological data, polysomnographic parameters, and subjective snoring questionnaire scores for the entire study cohort. There were no significant differences in these parameters between the PI and RF groups. There were no protocol deviation in this study and all participants received the intended intervention after randomization. At the end of study (July 30, 2012), there were 28 patients completed the protocol; two study cases were not available for follow-up (one for oversea work and one for military service; [Figure 1](#pone-0097186-g001){ref-type="fig"}). Thus data from 28 patients (PI group, *n* = 14; RF group: *n* = 14) were available for the intention-to-treat analyses. Moreover, no significant complication was noted during the study period.

10.1371/journal.pone.0097186.t001

###### Patient characteristics for the entire study cohort (*n* = 30).

![](pone.0097186.t001){#pone-0097186-t001-1}

                                       Overall      Palatal implant group   Radiofrequency group   Difference[\*](#nt102){ref-type="table-fn"}   *P* value
  --------------------------------- -------------- ----------------------- ---------------------- --------------------------------------------- -----------
  **Gender** (% male \[*n*\])          90 (27)            100 (15)                80 (12)                        20% (4% to 45%)                   0.073
  **Age** (years)                     36.7 (1.7)         38.3 (3.1)              35.1 (1.9)                     3.3 (−3.2 to 9.7)                  0.288
  **BMI** (kg/m^2^)                   24.2 (0.5)         24.7 (0.8)              23.6 (0.7)                     1.1 (−1.0 to 3.2)                  0.983
  **Neck circumference** (cm)         37.9 (0.6)         39.0 (0.9)              37.0 (0.9)                     2.0 (−0.6 to 4.6)                  0.391
  **Tonsil size**                     1.0 (0.03)           1.1 (0)                1.0 (0)                       0.1 (−0.1 to 0.2)                  0.317
  **Friedman\'s tongue position**     2.4 (0.09)          2.3 (0.1)              2.4 (0.1)                     −0.1 (−0.4 to 0.3)                  0.710
  **AHI** (events/hour)               7.8 (0.7)           7.9 (0.7)              7.7 (1.1)                      0.2 (−2.6 to 3.1)                  0.419
  **PSG-SI** (events/hour)           290.2 (38.4)       307.1 (48.0)            273.3 (55.2)                 33.8 (−126.0 to 193.6)                0.633
  **VAS**                             7.3 (0.4)           7.9 (0.5)              6.8 (0.6)                      1.1 (−0.3 to 2.5)                  0.384
  **SOS**                             40.5 (1.6)         40.4 (2.6)              40.5 (2.5)                    −0.1 (−6.9 to 6.7)                  0.934

Values were given as mean (standard error). AHI: apnea-hypopnea index. BMI: body mass index. CI: conference interval; PSG-SI: polysomnography-defined snoring index. SOS: snoring outcomes survey. VAS: visual analogue scale.

\*Statistical analyses were implemented with the Mann-Whitney *U* test.

Comparison of the Effects of PI and RF on Subjective Snoring Questionnaires {#s3b}
---------------------------------------------------------------------------

Changes in VAS scores after surgery were significant in both groups (PI group: 7.7 \[0.4\] *vs*. 4.4 \[0.6\], difference  = −3.3, 95% conference interval \[CI\], −5.0 to −1.6, *P* = 0.005; RF group: 6.6 \[0.5\] *vs*. 5.2 \[0.4\], difference = −1.4, 95% CI, −2.7 to −0.1, *P* = 0.022). Significant improvements in SOS scores were also noted in both groups (PI group: 39.4\[2.2\] *vs*. 62.2 \[3.2\], difference  =  22.8, 95% CI, 15.3 to 30.3, *P* = 0.002; RF group: 41.4 \[2.4\] *vs*. 54.4 \[2.5\], difference  =  13.0, 95% CI, 7.6 to 18.3, *P* = 0.001). Further, the mean change rate of VAS score in the PI group was significantly different from that in the RF group (−38.8% \[9.0%\] *vs*. −15.7% \[7.2%\], difference = 23.1%, 95% CI, −0.6% to 46.8%, *P* = 0.029). The mean change rate of SOS in the PI group was also significantly higher than that in the RF group (61.2% \[10.1%\] *vs*. 35.4% \[7.7%\], difference = 25.8%, 95% CI, −0.3% to 51.8%, *P* = 0.027).

[Table 2](#pone-0097186-t002){ref-type="table"} shows the results comparing the postoperative changes in subjective questionnaire scores after re-categorization between both groups. The rates of ΔVAS ≥1, ΔSOS ≥10, and response (ΔVAS ≥1 or ΔSOS ≥10) in both groups were not different. Twenty-nine percent of the PI group subjects reported mean postoperative VAS ≤3 (major response), and another 50% of the patients (fair response) complained of mild-to-moderate snoring (postoperative VAS ≤5) but had adequate functional outcomes (postoperative SOS ≥60). Only 7% of the RF group had major response after RF surgery, and 21% scored postoperative VAS ≤5 plus SOS ≥60 (fair response). Accordingly, the 'good response' rate was significantly higher in the PI group compared with the RF group (79% *vs.* 29%, difference  =  50%, 95% CI, 13% to 72%, *P* = 0.021).

10.1371/journal.pone.0097186.t002

###### Comparison of the postoperative changes in subjective questionnaire scores between the palatal implant and radiofrequency surgery groups.

![](pone.0097186.t002){#pone-0097186-t002-2}

  Subgroups, % (*n*)                                                                     Palatal implant group   Radiofrequency group         Ratio             Difference      *P* value
  ------------------------------------------------------------------------------------- ----------------------- ---------------------- -------------------- ------------------ -----------
  **ΔVAS ≥1**                                                                                   93 (13)                 64 (9)          1.44 (0.95--2.19)    29% (−3% to 55%)     0.165
  **ΔSOS ≥10**                                                                                  93 (13)                 57 (8)          1.63 (1.01--2.62)    36% (3% to 61%)      0.077
  **Postoperative VAS ≤3**                                                                      29 (4)                  7 (1)           4.00 (0.51--31.46)   21% (−8% to 48%)     0.326
  **Postoperative VAS ≤5 plus SOS ≥60**                                                         71 (10)                 29 (4)          2.50 (1.02--6.10)    43% (6% to 67%)      0.057
  **Response (Either ΔVAS ≥1 or ΔSOS ≥10)**                                                     93 (13)                71 (10)          1.30 (0.91--1.87)    21% (−8% to 48%)     0.326
  **Good response (Ether postoperative VAS ≤3 or postoperative VAS ≤5 plus SOS ≥60)**           79 (11)                 29 (4)          2.75 (1.15--6.58)    50% (13% to 72%)     0.021

CI: conference interval. SOS: snore outcomes survey. VAS: visual analogue scale.

Comparison of the Effects of PI and RF on Objective Snoring Sound Analysis {#s3c}
--------------------------------------------------------------------------

Despite the randomized parallel-controlled trial nature of this study, some conditions were different between the two groups. The patients in the PI group had a significantly higher mean preoperative Total-Imax (70.9 \[3.3\] *vs*. 57.7 \[2.1\], difference = 13.2, 95% CI, 4.9 to 21.4, *P* = 0.004) and B1-Imax (63.8 \[2.5\] *vs*. 53.9 \[2.0\], difference = 9.8, 95% CI, 3.1 to 16.5, *P* = 0.014) than those in the RF group ([Table 3](#pone-0097186-t003){ref-type="table"}).

10.1371/journal.pone.0097186.t003

###### Objective snoring sound parameters at baseline for the entire study cohort (*n* = 30).

![](pone.0097186.t003){#pone-0097186-t003-3}

                                          Overall      Palatal implant group   Radiofrequency group   Difference[\*](#nt105){ref-type="table-fn"}   *P* value
  ----------------------------------- --------------- ----------------------- ---------------------- --------------------------------------------- -----------
  **Total domain (40 Hz--2000 Hz)**                                                                                                                
  **SI** (events/hour)                 116.3 (22.3)        116.3 (23.7)            116.4 (38.4)                  −0.1 (−93.2 to 92.9)                 0.135
  **Imax** (dB)                         64.3 (2.3)          70.9 (3.3)              57.7 (2.1)                    13.2 (4.9 to 21.4)                  0.004
  **Imean** (dB)                        49.1 (1.2)          50.8 (1.3)              47.4 (2.0)                     3.4 (−1.4 to 8.3)                  0.054
  **Fpeak** (Hz)                       580.3 (107.6)       543.3 (150.8)          617.3 (158.6)                 −74.0 (−521.6 to 373.6)               0.709
  **Fmean** (Hz)                        101.9 (4.8)         101.4 (5.8)            102.3 (7.9)                   −0.9 (−21.0 to 19.2)                 0.868
  **B1 domain (40 Hz--300 Hz)**                                                                                                                    
  **SI** (events/hour)                 113.3 (22.3)        113.4 (23.6)            113.3 (38.5)                   0.1 (−92.9 to 93.1)                 0.135
  **Imax** (dB)                         58.9 (1.8)          63.8 (2.5)              53.9 (2.0)                     9.8 (3.1 to 16.5)                  0.004
  **Imean** (dB)                        46.0 (1.1)          47.2 (1.1)              44.8 (1.9)                     2.4 (−2.1 to 7.0)                  0.093
  **Fpeak** (Hz)                        219.0 (8.6)         217.3 (8.9)            220.7 (14.9)                  −3.3 (−39.0 to 32.3)                 0.934
  **Fmean** (Hz)                        100.0 (4.7)         98.0 (6.1)             101.9 (7.4)                   −3.9 (−23.7 to 15.8)                 0.494

Values were given as mean (standard error). AHI: apnea-hypopnea index. BMI: body mass index. CI: conference interval; PSG-SI: polysomnography-defined snoring index. SOS: snoring outcomes survey. VAS: visual analogue scale.

\*Statistical analyses were implemented with the Mann-Whitney *U* test.

In the PI group, the change of mean B1-Imax (64.5 \[1.9\] *vs*. 56.7 \[1.9\], difference  =  −7.9, 95% CI, −16.4 to 0.7, *P* = 0.048) was significant, whereas changes of the other acoustic parameters were insignificant ([Table 4](#pone-0097186-t004){ref-type="table"}). Although the mean B1-SI (121.2 \[40.4\] *vs*. 54.4 \[31.4\], difference  =  −66.9, 95% CI, −145.0 to 11.3, *P* = 0.041) was significantly reduced after surgery, the mean postoperative Total-Imax (58.3 \[2.2\] *vs*. 64.9 \[3.3\], difference = 6.7, 95% CI, 1.8 to 11.5, *P* = 0.016), Total-Imean (48.0 \[2.0\] *vs*. 56.3 \[2.9\], difference = 8.3, 95% CI, 2.3 to 14.2, *P* = 0.009), and B1-Imean (45.4 \[2.0\] *vs*. 51.6 \[2.6\], difference = 6.3, 95% CI, 1.1 to 11.4, *P* = 0.011) were significantly increased compared with the preoperative data in the RF group. As expected, the change rates of Total-Imax (−6.8% \[5.9%\] *vs*. 11.3% \[3.8%\], difference  =  −18.1%, 95% CI, −32.5% to −3.6%, *P* = 0.022), Total-Imean (−0.4% \[5.6%\]. *vs*. 18.2% \[6.1%\], difference  =  −17.9%, 95% CI, −34.9% to −0.9%\], *P* = 0.027), B1-Imax (−9.4% \[5.6%\] *vs*. 5.6% \[3.1%\], \[difference = −15.1%, 95% CI, −28.3%to −1.9%\], *P* = 0.024), and B1-Imean (−4.6% \[5.3%\] *vs*. 14.7% \[5.5%\], difference = −19.3, 95% CI, −34.9% to −3.3%\], *P* = 0.009) were significantly different between the PI group and RF group.

10.1371/journal.pone.0097186.t004

###### Results of objective snoring sound parameters before and after treatment in the two groups.

![](pone.0097186.t004){#pone-0097186-t004-4}

                                       Palatal implant group (*n* = 14)   Radiofrequency group (*n* = 14)                                                                   
  ----------------------------------- ---------------------------------- --------------------------------- --------------- --------------- ---------------- --------------- -----------------------
  **Total domain (40 Hz--2000 Hz)**                                                                                                                                         
  **SI** (events/hour)                           123.8 (24.8)                      101.3 (28.8)              −5.9 (25.6)    124.6 (40.3)     73.9 (34.2)     −48.9 (22.1)    43.1 (−11.1 to 97.3)
  **Imax** (dB)                                 72.1 (3.4)^A^                       65.1 (1.8)              −6.8 (5.9)^C^   58.3 (2.2)^A^   64.9 (3.3)^B^    11.3 (3.8)^C^   −18.1 (−32.5 to −3.6)
  **Imean** (dB)                                  50.9 (1.4)                        50.6 (2.6)              −0.4 (5.6)^C^    48.0 (2.0)     56.3 (2.9)^B^    18.2 (6.1)^C^   −17.9 (−34.9 to −0.9)
  **Fpeak** (Hz)                                570.7 (161.9)                      570.0 (146.6)              −6 (24.2)     651.5 (163.4)   477.9 (122.0)    −12.1 (26.2)     6.1 (−33.9 to 69.3)
  **Fmean** (Hz)                                 100.7 (6.2)                        99.6 (8.6)               −0.9 (8.7)      104.6 (8.1)     89.8 (12.7)     −10.9 (11.6)    10.0 (−18.0 to 41.5)
  **B1 domain (40 Hz**--**300 Hz)**                                                                                                                                         
  **SI** (events/hour)                           120.8 (24.7)                      116.2 (30.9)              −1.7 (29.5)    121.2 (40.4)    54.4 (31.4)^B^   −51.8 (22.5)    50.1 (−3.9 to 110.9)
  **Imax** (dB)                                 64.5 (2.6)^A^                      56.7 (1.9)^B^            −9.4 (5.6)^C^   54.4 (2.1)^A^     57.4 (2.6)     5.6 (3.1)^C^    −15.1 (−28.3 to −1.9)
  **Imean** (dB)                                  47.2 (1.2)                        44.7 (2.2)              −4.6 (5.3)^C^    45.4 (2.0)     51.6 (2.6)^B^    14.7 (5.5)^C^   −19.3 (−34.9 to −3.3)
  **Fpeak** (Hz)                                 222.1 (9.6)                       192.9 (15.9)              −10.9 (7.9)    226.4 (13.9)     142.1 (25.6)    −33.5 (11.4)     22.6 (−6.0 to 51.1)
  **Fmean** (Hz)                                  97.0 (6.6)                        95.2 (6.9)               −1.6 (8.4)      103.9 (7.6)      75.0 (9.4)      −24.8 (8.7)     22.2 (−1.5 to 51.3)

CI: conference interval. Fmean: mean sound frequency. Fpeak: peak sound frequency. Imax: maximal sound intensity. Imean: mean sound intensity.

Discussion {#s4}
==========

This is the first study to compare the anti-snoring effects in two MIS of the soft palate, PI and RF, using both objective and subjective evaluations. Clinically, RF surgery is more widely used and investigated, while PI surgery has received increasing attention, although their efficacy in changing the objective characteristics of snoring sounds remains uncertain. Our results suggest that both PI and RF surgeries were safe and improved subjective snoring severity and functional outcomes; however there were differences in their effects on acoustic characteristics. Furthermore, PI surgery had a greater effect on a favorable surgical response than one-session of RF surgery in this randomized parallel-controlled trial.

Previous functional outcome studies of palatal MIS are limited, and most have used VAS score to measure the differences. The VAS for snoring assessment is a standardized, well-established tool to measure the subjective intensity of snoring. Many reports have shown that the patients who receive MIS for snoring usually have a high (\>7) VAS score [@pone.0097186-Bck1]--[@pone.0097186-Franklin1]. Nevertheless, only a few studies have demonstrated a MIS reduction in VAS snoring score to ≤3 [@pone.0097186-Fang1], [@pone.0097186-Goessler1]--[@pone.0097186-Powell1], [@pone.0097186-Coleman1]--[@pone.0097186-Terris1]. Although MIS rarely cures snoring in subjective evaluation, it has been shown to effectively alleviate snoring in several randomized placebo-controlled trials [@pone.0097186-Stuck2], [@pone.0097186-Friedman1], [@pone.0097186-Steward1], [@pone.0097186-Maurer1]. Further, VAS alone cannot reflect the whole profile of snoring and related consequences. Accordingly, full outcome analysis of MIS for snoring should include other snoring-related outcomes such as the Functional Outcomes of Sleep Questionnaire (FOSQ) [@pone.0097186-Nordgrd1] or SOS [@pone.0097186-Gliklich1]. Steward et al. reported that PI surgery could improve FOSQ scores more significantly than placebo [@pone.0097186-Steward1]. In our previous study, the SOS score significantly increased following one-session of RF surgery [@pone.0097186-Fang1].

Theoretically, both PI and RF surgery stiffens the muscle layer of the soft palate in order to reduce the palatal flutter [@pone.0097186-Ho1], [@pone.0097186-Weaver1]. Previous studies have indicated that patients with mild obstructive sleep apnea or simple snoring have peak intensities between 100 and 300 Hz (B1-domain) [@pone.0097186-Lee1], [@pone.0097186-Herzog1], [@pone.0097186-Courey1]. As expected, this study found that the two MIS mainly influenced B1-snoring sounds although in different dimensions. That is, the distinct mechanisms of the palatal rigidity can also alter the surrounding airway structures that can then produce different snoring sounds.

To the best of our knowledge, there are currently no reports on changes of the upper airway structure or changes in acoustic characteristics after PI surgery. Clinically, the shape and size of the uvula and soft palate do not change after PI procedure. However, polyethylene teralphate implants can be regarded as an extension of the hard palate to prop up and stiffen the soft palate in a rectangular area by approximately 1.8 cm (length) x 0.94 (0.18 + 0.2 + 0.18 + 0.2 + 0.18) cm (width; [Figure 3B](#pone-0097186-g003){ref-type="fig"}). It seems that the PI strengths the uvular muscle ([Figure 1A](#pone-0097186-g001){ref-type="fig"}) and consequently confines palatal flutter leading to the reduction in B1-Imax. Of note, VAS and SOS improved significantly in spite of insignificant reductions in other B1-domain parameters in the PI group.

In contrast, RF energy may affect the soft palate in a long oval area by approximately 1.0 cm (length) x 2.6 cm (width) based on our surgical technique ([Figure 4B](#pone-0097186-g004){ref-type="fig"}). The location of the RF treatment includes the musculus uvulae (midline position 600 J) and combination of levator veli palatini and palatopharyngeus (para-midline positions 300 J each). Bäck et al. used magnetic resonance imaging to evaluate soft palates that received two sessions of bipolar RF energy, and found that the scar tissue formation resulting in the T1-signal intensity of the soft palate increased significantly three months after treatment [@pone.0097186-Goessler1].

In this study, the subjective improvement rates in the VAS and SOS were significantly lower in the RF group than the PI group despite having the same inclusion criteria with regards to anatomy. Moreover, B1-SI decreased significantly without respect to the increase in B1-Imean. Since the length and width of the soft palate could not be significantly changed by RF surgery despite scaring of the soft palate [@pone.0097186-Goessler1], the non-operated part (at least 0.5 cm; 2.5 -- 1.0 -- 1.0 = 0.5) and insufficient longitudinal rigidity of the uvular muscle in one single session RF treatment cannot resist a higher inspiratory force resulting in louder B1-snores. In contrast, we presume that RF energy works on the tensor veli palatine and palatopharyngeus muscles in a horizontal direction ([Figure 1A](#pone-0097186-g001){ref-type="fig"}) and tenses up the soft palate to resist lower inspiratory force thereby decreasing the occurrence of B1-snores. These findings imply the necessity of more treatment sessions or multiple midline longitudinal injection sites in RF surgery of the soft palate to reduce the intensity of snoring, and the application of additional PI in the tensor veli palatine muscle to decrease SI.

The major limitation to this study is unbalanced randomization in Total-Imax despite insignificant differences in baseline anthropologic, symptomatic, and polysomnographic parameters between the two groups. This may be a methodological flaw in such a prospective randomized controlled trial, although this was not predicted before the study was undertaken. Moreover, the small sample size creates at least a few limitations: unable to do subgroup analyses, risk of unbalanced allocation of patients (i.e., imperfect randomization can be a consequence of the small sample size), and statistical difference between groups is seen only when there are large differences (i.e., smaller differences are not statistically significant, even if clinically important). A future study with a larger sample could overcome these limitations. Although our study indicated PI surgery may be more efficacious in the treatment of snoring for adult patients with simple snoring, it will be important to test the effects of this MIS technique with more anthropologically and ethnically diverse subjects in a larger sample.

Conclusions {#s5}
===========

Both PI and RF alleviated subjective snoring intensity and improved snoring-related outcomes; however, the changes in magnitude and pattern in the acoustic parameters of snoring differed between these two MIS techniques. Our study indicated PI surgery may be more efficacious than single-stage RF surgery in the treatment of snoring for adult patients with simple snoring, it will be important to test the effects of this MIS technique with more anthropologically and ethnically diverse subjects in a larger sample. Further research evaluating the histoanatomical and acoustic changes within the soft palate to predict treatment outcomes is warranted.
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